{2 (magnesium sulfate 900 MG / polyethylene glycol 3350 179000 MG / potassium chloride 112... — RxCUI 2641143
RxNorm drug concept · Generic pack
RxCUI 2641143
Generic pack · GPCK
● Current RxNorm concept 2 FDA products
2 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2641143
Official name{2 (magnesium sulfate 900 MG / polyethylene glycol 3350 179000 MG / potassium chloride 1120 MG / sodium chloride 500 MG / sodium sulfate 7300 MG Powder for Oral Solution) } Pack
Concept typeGeneric pack (GPCK)
RxNorm statusCurrent RxNorm concept
Also known asBowel Prep Kit (polyethylene glycol 3350 178.7 GM / potassium chloride 1.12 GM / magnesium sulfate 0.9 GM / sodium chloride 0.5 GM / sodium sulfate 7.3 GM) Powder for Oral Solution
FDA products mapped2
Package NDCs mapped2
Reported Medicaid activity (SDUD)28,515 prescriptions · 26 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Polyethylene Glycol 3350: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- You can generally expect a bowel movement within 1 to 3 days after taking it. It's not meant to work in an hour like some other laxatives — it works gradually. If you haven't gone...
- How long does it take for Polyethylene Glycol 3350 to work?
- You can stir it into any 4 to 8 ounces of beverage — water, juice, coffee, tea, whatever you like, cold or hot. The key is to stir it well until it's completely dissolved. Don't dr...
- Can I mix it into any drink, or does it have to be water?
🕸️ Concept Web — How {2 (magnesium sulfate 900 MG / polyethylene glyc... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
{2 (magnesium sulfate 900 MG / polyethylene glycol 3350 179000 MG / potassium chloride 1120 MG / sodium chloride 500 MG / sodium sulfate 7300 MG Powder for Oral Solution) } Pack
RxCUI 2641143 Generic pack · GPCK
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 6
The active substance itself — no strength, form, or brand attached yet.
-
Magnesium sulfate
6585IN -
Polyethylene glycol 3350
221147IN -
Potassium chloride
8591IN -
Sodium chloride
9863IN -
Sodium sulfate
36721IN -
Magnesium sulfate / polyethylene glycol 3350 / potassium chloride / sodium chloride / sodium sulfate
2641138MIN
-
Magnesium sulfate
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Magnesium sulfate / polyethylene glycol 3350 / potassium chloride / sodium chloride / sodium sulfate Powder for Oral Solution
2641141SCDF -
Magnesium sulfate / polyethylene glycol 3350 / potassium chloride / sodium chloride / sodium sulfate Oral Powder Product
2641140SCDG -
Magnesium sulfate / polyethylene glycol 3350 / potassium chloride / sodium chloride / sodium sulfate Oral Product
2641139SCDG -
Pack
746839DF -
Oral Powder Product
1294711DFG -
Oral Product
1151131DFG
-
Magnesium sulfate / polyethylene glycol 3350 / potassium chloride / sodium chloride / sodium sulfate Powder for Oral Solution
-
Clinical & branded drugs 6
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Magnesium sulfate 900 MG / polyethylene glycol 3350 179000 MG / potassium chloride 1120 MG / sodium chloride 500 MG / sodium sulfate 7300 MG Powder for Oral Solution
2641142SCD -
Magnesium sulfate 900 MG
2641136SCDC -
Polyethylene glycol 3350 179000 MG
2641134SCDC -
Potassium chloride 1120 MG
2641135SCDC -
Sodium chloride 500 MG
451689SCDC -
Sodium sulfate 7300 MG
2641137SCDC
-
Magnesium sulfate 900 MG / polyethylene glycol 3350 179000 MG / potassium chloride 1120 MG / sodium chloride 500 MG / sodium sulfate 7300 MG Powder for Oral Solution
-
Packs 1
Fixed collections of drugs packaged and sold together, like dose packs.
Showing up to 8 concepts per family — 19 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Magnesium sulfate 900 MG / polyethylene glycol 3350 179000 MG / potassium chloride 1120 MG / sodium chloride 500 MG / sodium sulfate 7300 MG Powder for Oral Solution
SCD · 2641142 -
Magnesium sulfate 900 MG
SCDC · 2641136 -
Polyethylene glycol 3350 179000 MG
SCDC · 2641134 -
Potassium chloride 1120 MG
SCDC · 2641135 -
Sodium chloride 500 MG
SCDC · 451689 -
Sodium sulfate 7300 MG
SCDC · 2641137 -
Magnesium sulfate / polyethylene glycol 3350 / potassium chloride / sodium chloride / sodium sulfate Powder for Oral Solution
SCDF · 2641141 -
Magnesium sulfate / polyethylene glycol 3350 / potassium chloride / sodium chloride / sodium sulfate Oral Powder Product
SCDG · 2641140 -
Magnesium sulfate / polyethylene glycol 3350 / potassium chloride / sodium chloride / sodium sulfate Oral Product
SCDG · 2641139
📦 FDA Products & Package NDCs
2 products · 2 package NDCs
2 package NDCs map to RxCUI 2641143 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 24338-0550-01 | 1 KIT in 1 KIT (24338-550-01) | SUFLAVE | Azurity Pharmaceuticals, Inc. | 2026-04-01 |
| 52268-0550-01 | 1 KIT in 1 KIT (52268-550-01) | SUFLAVE | Braintree Laboratories, Inc. | 2023-06-15 |
Observed labelers:
Azurity Pharmaceuticals, Inc. (1) ·
Braintree Laboratories, Inc. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.